LOW ENDOPHTHALMITIS RATES AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS IN AN OPERATION ROOM: A Retrospective Multicenter Study. Issue 12 (December 2017)
- Record Type:
- Journal Article
- Title:
- LOW ENDOPHTHALMITIS RATES AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS IN AN OPERATION ROOM: A Retrospective Multicenter Study. Issue 12 (December 2017)
- Main Title:
- LOW ENDOPHTHALMITIS RATES AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS IN AN OPERATION ROOM
- Authors:
- Freiberg, Florentina J.
Brynskov, Troels
Munk, Marion R.
Sørensen, Torben L.
Wolf, Sebastian
Wirth, Magdalena A.
Becker, Matthias
Michels, Stephan - Abstract:
- Abstract : Purpose: To evaluate the rate of presumed endophthalmitis (EO) after intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections in three European hospitals performed in an operation room (OR) under sterile conditions. Methods: A retrospective multicenter study between 2003 and 2016 at three European sites, City Hospital Triemli Zurich, Switzerland (CHT), Zealand University Hospital Roskilde, Denmark (ZUH) and University Clinic Bern, Switzerland (UCB). Intravitreal injection (IVI) database of each department was reviewed. All anti-vascular endothelial growth factor injections were performed using a standardized sterile technique in an operation room. Injection protocols were similar between the three sites. No preinjection antibiotics were given. Postoperative antibiotics varied among sites. Results: A total of 134, 701 intravitreal injections were performed at the 3 sites between 2003 and 2016. Ten cases of presumed endophthalmitis were documented: 4 in 50, 721 at CHT (95% CI: 0.0071–0.0087%), 2 in 44, 666 at ZUH (95% CI: 0.0039–0.0051%), and 4 in 39, 314 at UCB (95% CI: 0.0092–0.011%). This results in one case in 13, 470 intravitreal injections and a combined incidence of 0.0074% per injection (95% CI: 0.0070–0.0078%). Positive cultures were found in 4 out of 10 presumed endophthalmitis cases. Conclusion: The standardized sterile technique in an operation room with laminar airflow showed very low rates of endophthalmitis at three European sites.Abstract : Purpose: To evaluate the rate of presumed endophthalmitis (EO) after intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections in three European hospitals performed in an operation room (OR) under sterile conditions. Methods: A retrospective multicenter study between 2003 and 2016 at three European sites, City Hospital Triemli Zurich, Switzerland (CHT), Zealand University Hospital Roskilde, Denmark (ZUH) and University Clinic Bern, Switzerland (UCB). Intravitreal injection (IVI) database of each department was reviewed. All anti-vascular endothelial growth factor injections were performed using a standardized sterile technique in an operation room. Injection protocols were similar between the three sites. No preinjection antibiotics were given. Postoperative antibiotics varied among sites. Results: A total of 134, 701 intravitreal injections were performed at the 3 sites between 2003 and 2016. Ten cases of presumed endophthalmitis were documented: 4 in 50, 721 at CHT (95% CI: 0.0071–0.0087%), 2 in 44, 666 at ZUH (95% CI: 0.0039–0.0051%), and 4 in 39, 314 at UCB (95% CI: 0.0092–0.011%). This results in one case in 13, 470 intravitreal injections and a combined incidence of 0.0074% per injection (95% CI: 0.0070–0.0078%). Positive cultures were found in 4 out of 10 presumed endophthalmitis cases. Conclusion: The standardized sterile technique in an operation room with laminar airflow showed very low rates of endophthalmitis at three European sites. Abstract : To study the rate of endophthalmitis (EO) after intravitreal injections (IVI) of anti-vascular endothelial growth factor performed in an operation room under standardized sterile techniques. The evaluation of 134, 701 intravitreal injections revealed 10 endophthalmitis cases and thus very low rates of post intravitreal injections endophthalmitis in comparison with reported incidence rates. … (more)
- Is Part Of:
- Retina. Volume 37:Issue 12(2017:Dec.)
- Journal:
- Retina
- Issue:
- Volume 37:Issue 12(2017:Dec.)
- Issue Display:
- Volume 37, Issue 12 (2017)
- Year:
- 2017
- Volume:
- 37
- Issue:
- 12
- Issue Sort Value:
- 2017-0037-0012-0000
- Page Start:
- Page End:
- Publication Date:
- 2017-12
- Subjects:
- intravitreal injections -- endophthalmitis -- safety -- operating room -- anti-VEGF -- laminar airflow
Retina -- Diseases -- Periodicals
Retinal Diseases
Vitreous Body
617.735 - Journal URLs:
- http://journals.lww.com/retinajournal/pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/IAE.0000000000001488 ↗
- Languages:
- English
- ISSNs:
- 0275-004X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7785.510300
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 8635.xml